US Patent 8008001 PCV-2 vaccine
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+645 characters)
Article
Patent abstract
The present invention relates to a vaccine and a method for protecting piglets against PCV-2 infection by administering a vaccine comprising at least 20 micrograms/dose of ORF-2 protein of porcine circovirus type 2, even when they have a relatively high titer of maternally derived antibodies against PCV-2. A vaccine according to the invention may contain a recombinant ORF-2 protein, wherein said recombinant protein is preferably produced by way of expression from a baculovirus expression vector in insect cells, said baculovirus expression vector containing the PCV-2 ORF-2 gene sequence under control of a suitable promoter.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008001 PCV-2 vaccine US Patent 8008001 PCV-2 vaccine
Infobox
Patent Number
0800800100
Patent Number
800800100
Edits on 26 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080010
Date of Patent
August 30, 2011
0Patent Application Number
126361430
Date Filed
December 11, 2009
0Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
080080010
Date of Patent
August 30, 2011
0Patent Application Number
126361430
Date Filed
December 11, 2009
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 08008001 PCV-2 vaccine
Infobox
Is a
Patent jurisdiction
Patent number
08008001
Date of patent
August 30, 2011
Patent application number
12636143
Date Filed
December 11, 2009
Patent primary examiner
Find more entities like US Patent 8008001 PCV-2 vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
